Our EXHIBITORS
AHEAD Medicine, an innovative healthtech firm, introduces the Cyto-copilot platform to advance flow cytometry analysis, enhancing disease diagnosis and cell therapy quality. Our technology is featured in the 16th chapter of the Flow Cytometry Protocol, and our CEO, Andrea, has been honored as the 2024 ISAC International Innovator. Additionally, AHEAD actively participates in the NIST flow cytometry standards consortium, supporting centralized data analysis to improve quality assurance in cell therapy.
Millennium Science - Igniting biomedical discovery
We distribute cutting-edge instruments and reagents for:
Genomics, Cancer, Immunology, Imaging, Protein Analysis, Cell Biology, Sample Prep, Screening, Drug & Antibody Discovery, Assay Kits, Cell Culture & more!
www.mscience.com.au | sales@mscience.com.au
Twitter: @mscienceaustnz
Discover Dotmatics, modern flow cytometry software reimagined. Whether for clinical labs, research or regulated GxP environments, Dotmatics meets every cytometry analysis need. Our leading software and solutions, FCS Express and OMIQ, have you covered from easy to use software that takes you from raw data to results in minutes, to powerful ML for auto-gating and biomarker discovery in high dimensional data. Discover why 2 million scientists and 10,000 customers trust Dotmatics.
Access customised solutions and a knowledge bank of experienced scientists to help refine your research.
Explore Proteintech's range of top-cited flow antibody clones which are conjugated to a variety of dyes to simplify your research. Flow panels also available to help you find your desired cell population (PE channel left open for your target of choice).
Sysmex Corporation is a global leader in diagnostics. Founded in 1968, Sysmex supports the health of people in over 190 countries worldwide. Sysmex has flow cytometry at the heart of our technologies. In Australia >80% of every FBC occurs on Sysmex haematology technology. With our partners Sony Biotechnology, we provide leading edge spectral and conventional flow cytometry to both research and clinical settings. We look forward to meeting you in Hobart.
Acknowledgement of Country
We acknowledge the muwinina people, the traditional owners of the Land upon which we work, and we pay our respect to Aboriginal Elders; past and present. We respect all Tasmanian Aboriginal people, their culture and their rights as the first peoples of lutruwita.